Biotech · Private company · Omaha, NE, US
Sanguine Diagnostics And Therapeutics
Track this companyFree. Adds Sanguine Diagnostics And Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Anti-MUC16 humanized antibody combination regimen for targeting metastasis in pancreatic cancerFiscal year 2026 · $400KNIH RePORTER 1R44CA306744-01A1 · fetched Nov 12, 2026